Filing Details
- Accession Number:
- 0001181431-12-052899
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-10-02 16:07:54
- Reporting Period:
- 2012-10-01
- Filing Date:
- 2012-10-02
- Accepted Time:
- 2012-10-02 16:07:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
31791 | Perkinelmer Inc | PKI | Laboratory Analytical Instruments (3826) | 042052042 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1224110 | F Robert Friel | 940 Winter Street Waltham MA 02451 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-10-01 | 50,565 | $22.58 | 560,679 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-10-01 | 50,565 | $29.52 | 510,114 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | NQ Stock Option (right to buy) | Disposition | 2012-10-01 | 50,565 | $0.00 | 50,565 | $22.58 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2013-01-31 | No | 4 | M | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Mr. Friel on May 08, 2012, and all transactions under that 10b5-1 trading plan have now been completed.
- The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $29.310 to $29.760. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- This option became exercisable in three equal annual installments beginning on January 31, 2007, which was the first anniversary of the date on which the option was granted.